Summary
Increased functional properties of diabetic platelets might be already conditionated during thrombopoiesis in the stem cell system. This hypothesis was studied by recording the distribution characteristics of the peripheral platelet pool in 218 diabetic patients versus 51 controls. Furthermore, platelet membrane coating with the stem cell marker glycoprotein IB was analyzed in 41 diabetic subjects and compared to 23 healthy volunteers. A consistant, significant shift of the volume distribution to larger platelets was found in diabetics: Mean platelet volume (MPV) — 7.9±0.9 versus 7.2±0.8 [fl]; Megathrombocyte index (MTI) — 20.4±2.8 versus 18.1±2.5 [fl]. These deviations were present in all patient subsets, however did not correlate to parameters of glucose metabolism. Whole blood platelet count was increased in the patient group: 195.0±59.5 versus 184.0±37.5×103 plts/ul. Coating with glycoprotein IB receptors correlated significantly to platelet size in platelets of both controls and diabetics (r normal=0.52±0.07;r diabetic=0.46±0.1). The quantitativ expression of glycoprotein IB was significantly enhanced in the diabetic group: 54500×1.28±1 versus 39100×1.3±1 molecules per platelet. In conclusion, these findings strongly support the assumption of diabetic stem cell dysfunction of the megakaryocytic series and progenitor cells resulting in platelets with primarily increased potency to adhere and aggregate in diabetes mellitus.
Similar content being viewed by others
Abbreviations
- F(ab)2 :
-
fragment (ab)2
- g:
-
gravitation force
- fl:
-
femtolitre
- log:
-
logarithmus to 10
- nm:
-
nanometer
- PBS:
-
phosphate buffered saline
- µl:
-
microliter
- µM:
-
micromolar
- MPV:
-
mean platelet volume (geometric mean)
- MTI:
-
megathrombocyte index (=95% percentile)
- GPIB:
-
glycoprotein IB
- plts:
-
platelets
References
Baumgartner HR, Sakariassen KS (1987) Factors Controlling Thrombus Formation on Arterial Lesions. Ann NY Acad Sci. pp 162–177
Berndt MC (1986) The Molecular Mechanism of Platelet Adhesion. In: Fidge NH, Nestel PJ (eds) Athersclerosis VII, Springer, Berlin Heidelberg New York, pp 467–471
Betteridge DJ, El Tahir KEH, Reckless JPD, Williams KI (1982) Platelets from diabetic subjects show diminished sensitivity to prostacyclin. Eur J Clin Invest 12:395–398
Betteridge DJ, Zahavi J, Jones NAG, Shine B, Kakkar VV, Galton DJ (1981) Platelet function in diabetes mellitus in relationship to complications, glycosylated haemoglobin and serum lipoproteins. Eur J Clin Invest 11:273–277
Boneu B, Boneu A, Raisson Cl, Guiraud R, Bierme R (1973) Kinetics of Platelet Populations in the stationary State. Thrombosis Res 3:605–611
Burrows AW, Chavin SI, Hockaday TDR (1978) Plasma-Thromboglobulin Concentrations in Diabetes Mellitus. Lancet 2/4:235–237
Collier A, Tymkewycz PM, Matthews DM, Jones RL, Clarke BF (1987) Changes in some Aspects of Platelet Function with Improvement of Glycaemic Control over 6 months. Diabetes Research 5:79–82
Colwell JA, Winocour PD, Halushka PV (1983) Do Platelets have anything to do with Diabetic Microvascular Disease? Diabetes 32 (Suppl 2):14–19
Colwell JA, Sagel J, Crook L, Chambers A, Laimins M (1977) Correlation of Platelet Aggregation, Plasma Factor Activity, and Megathrombocytes in Diabetic Subjects With and Without Vascular Disease. Metabolism 26/3:279–285
Denfors I, Wadenvik H, Kutti J (1987) Preparation of a representative platelet population by a single step slow centrifugation. Thromb Haemostas 58/1:473
Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF (1988) Nerve Glucose, Fructose, Sorbitol, myo-Inositol, and Fiber Degeneration and Regeneration in Diabetic Neuropathy. New Engl J Med 319/9:542–548
Garg SK, Amorosi EL, Karpatkin S (1971) Use of the Megathrombocyte as an Index of Megakaryocyte Number. New Engl J Med 284/1:12–17
Greene DA, Lattimer S, Ulbrecht J, Carroll P (1985) Glucose-induced Alterations in Nerve Metabolism: Current Perspective on the Pathogenesis of Diabetic Neuropathy and Future Directions for Research and Therapy. Diabetes Care 8/3:290–299
Halushka PV, Rogers RC, Loadholt CB, Wohltman H, Mayfield R, McCoy S, Colwell JA (1981) Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus. Hormone metabol Res 11 Suppl:7–11
Haviger J, Kloczewiak M, Timmons S (1985) Platelet Receptor Mechanisms for Adhesive Macromolecules. In: JA Oates, J Haviger, R Ross (eds) Interaction of Platelets with the Vessel Wall. American Physiological Society, Bethesda, Maryland, pp 1–20
Janson Leif (1985) Relationship of mean platelet volume to platelet count in morphologic evaluation of thrombopoiesis. Scand J Haematol 35:363–366
Jones RL, Peterson CM (1981) Hematologic Alterations in Diabetes Mellitus. Am J Med 70:339–352
Jones RL, Paradise C, Peterson CM (1981) Platelet Survival in Patients with Diabetes Mellitus. Diabetes 30:486–489
Kanz L, Löhr GW, Fauser AA (1987) Human Megakaryocytic Progenitor cells. Klin Wochenschr 65:297–307
Karpatkin S, Heterogeneity of Rabbit Platelets (1978) Br J Haematol 39:459–469
Karpatkin S (1978) Heterogeneity of Human Platelets. VI. Correlation of Platelet Function With Platelet Volume. Blood 51/2:307–315
Karpatkin S (1972) Human Platelet Senescence. Ann Rev Med 23:101–128
Leone G, Agostini A, DeCrescenzo A, Bizzi B (1979) Platelet Heterogeneity. Scand J Haematol 23:204–210
Martyn CN, Matthews DM, Popp-Snijders C, Tucker J, Ewing DJ, Clarke BF (1986) Effects of Sorbinil Treatment on Erythrocytes and Platelets of Persons with Diabetes. Diabetes Care 9/1:36–39
Mayfield RK, Halushka PV, Wohltman HJ, Lopes-Virella M, Chambers JK, Loadholt CB, Colwell JA (1985) Platelet Function During Continuous Insulin Infusion Treatment in Insulin-dependent Diabetic Patients. Diabetes 34:1127–1133
Nurden AT (1987) Platelet membrane glycoproteins and their clinical aspects. In: Verstraete M, Vermylen J, Lijnen R, Arnout J (eds) Thrombosis and Haemostasis, Leuven University Press, pp 93–125
Ostermann H, van de Loo J (1986) Factors of the Hemostatic System in Diabetic Patients — A Survey of Controlled Studies. Haemostasis 16/6:386–416
Paton RC (1979) Platelet Survival in Diabetes Mellitus using an Aspirin-labelling Technique. Thrombosis Res 15, 5/6:793–802
Paulus JM (1975) Platelet Size in Man. Blood 46/3:321–336
Paulus JM, Bury J, Grosdent JC (1979) Control of Platelet Territory Development in Megakaryocytes. Blood Cells 5:59–88
Pennington DG, Lee NLY, Roxburgh AE, McGready JR (1976) Platelet Density and Size: the Interpretation of Heterogenity. Br J Haematol 34:365–376
Porta M (1982) Availability of Endothelial von Willebrand Factor and Platelet Function in Diabetic Patients Infused with a Vasopressin Analogue. Diabetologia 23:452–455
Porta M, Kohner EM, Molinatti GM (1987) In vivo Studies of Endothelial Cell Function in Diabetic Microangiopathy. In: Belfiore F (ed) Front Diabetes. Karger, Basel, pp 16–28
Preston FE, Ward JD, Marcola BH, Porter NR, Timperley WR (1978) Elevated β-Thromboglobulin Levels and Circulating Platelet Aggregates in Diabetic Microangiopathy. Lancet 2/4:238–239
Rosove MH, Harrison JLF, Harwig SSL (1984) Plasmaβ-Thromboglobulin, Platelet Factor 4, Fibrinopeptide A and other Hemostatic Functions During Improved, Shortterm Glycemic Control in Diabetes mellitus. Diabetes Care 7/2:174–179
Rösen P, Hohl C (1984) Prostaglandins and Diabetes. Ann Clin Res 16/5–6:300–313
Rösen P, Hohl C, Tschöpe D, Körner A, Halfmann U, Berger M (1987) Thromboxane and 6-Oxo-PGF1a in the Plasma of Patients with Diabetes Type I and II. Prostaglandins in Clinical Research. Alan R Liss, New York, pp 247–252
Sagel J, Colwell JA, Crook L, Laimins M (1975) Increased Platelet Aggregation in Early Diabetes Mellitus. Ann Int Med 82:733–738
Sachs L (1984) Angewandte Statistik (fourth edition) Springer, Berlin Heidelberg New York Tokyo
Schneider W (1988) Bedeutung von Hämostasestörungen für Diagnostik und Therapie von Tumorkrankheiten. Hämostaseologie 8:34–46
Sixma J (1987) Platelet Adhesion in Health and Disease. In: Verstraete M, Vermylen J, Lijnen R, Arnout J (eds) Thrombosis Haemostasis, Leuven University Press, pp 127–146
Stout RW (1987) The Endothelial Cell in Diabetes. In: Belfiore F (ed) Front Diabetes. Karger, Basel, pp 116–124
Thompson CB, Love DG, Quinn PG, Valeri CR (1983) Platelet Size Does Not Correlate With Platelet Age. Blood 62/2:487–494
Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR (1983) Platelet size as a determinant of platelet function. J Lab Clin Med 101/2:205–213
Tindall H, Paton RC, Zuzel M, McNicol GP (1981) Platelet Life Span in Diabetics with and without Retinopathy. Thromb Res 21:641–648
Tschöpe D, Langer E, Gries FA (1986) Increased Platelet Volume in Diabetes Mellitus. Diabetes 35/1:131a
Tschöpe D, Langer E, Schumacher M, Rösen P, Gries FA (1986) “DigiSize”: A Computer Based Analysis of Circulating Platelet Population — Experiences in Diabetics. Haemostasis 16/5:15
Tschöpe D, Rösen P, Kaufmann L (1987) Increased content of alpha granule proteins and thromboxane synthesis in type II diabetic platelets. Diabetes 36 Suppl 1:126a
Tschöpe D, Schauseil S, Roesen P, Kaufmann L, Gries FA (1988) Flow-cytometric Determination of Platelet Membrane Bound Glycoproteins. Klin Wochenschr 66:117–122
Voisin PJ, Rousselle D, Streiff F, Debry G, Stoltz J-F, Drouin P (1983) Reduction of Beta-Thromboglobulin Levels in Diabetics Controlled by Artificial Pancreas. Metabolism 32/2:138–141
Watanabe Y (1987) Effect of Insulin on Murine Megakaryocytopoiesis in a Liquid Culture System. Cell Structure and Function 12/3:311
Wehmeier A, von Blohn G, Buerstedde V, Schneider W (1986) Variability of Platelet Volume Determination: Influence of Anticoagulants, Incubation Time, Temperature and Red Blood Cells. Haemostasis 16 Suppl 5:16
Winkelmann M, Pfitzer P, Schneider W (1987) Significance of Polyploidy in Megakaryocytes and Other Cells in Health and Tumor Disease. Klin Wochenschr 65:1115–1131
Winocour PD, Laimins M, Colwell JA (1984) Platelet Survival in Streptozotocin-Induced Diabetic Rats. Thromb Haemostas 51/3:307–312
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tschöpe, D., Langer, E., Schauseil, S. et al. Increased platelet volume — Sign of impaired thrombopoiesis in diabetes mellitus. Klin Wochenschr 67, 253–259 (1989). https://doi.org/10.1007/BF01717328
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01717328